Cardlytics Financial Statements (CDLX)
|
|
|
|
Report date
|
|
|
01.03.2021 |
01.03.2022 |
31.12.2022 |
01.03.2023 |
14.03.2024 |
|
06.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
186.9 |
267.1 |
298.5 |
298.5 |
309.2 |
|
293.5 |
|
Operating Income, bln rub |
|
|
-53.9 |
-96.9 |
0.000 |
-135.5 |
-135.7 |
|
-194.7 |
|
EBITDA, bln rub |
? |
|
-39.5 |
-89.9 |
-417.5 |
-419.0 |
-99.0 |
|
-238.9 |
|
Net profit, bln rub |
? |
|
-58.5 |
-128.6 |
-465.3 |
-465.3 |
-134.7 |
|
-274.6 |
|
|
OCF, bln rub |
? |
|
-7.60 |
-38.5 |
-53.9 |
-53.9 |
-0.185 |
|
-8.87 |
|
CAPEX, bln rub |
? |
|
10.1 |
12.6 |
13.3 |
13.5 |
12.4 |
|
22.9 |
|
FCF, bln rub |
? |
|
-17.7 |
-51.1 |
-67.2 |
-67.4 |
-12.6 |
|
-12.6 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
117.2 |
200.2 |
756.3 |
248.2 |
195.8 |
|
173.8 |
|
Cost of production, bln rub |
|
|
123.6 |
163.8 |
0.000 |
185.9 |
178.8 |
|
163.7 |
|
R&D, bln rub |
|
|
17.5 |
38.1 |
54.4 |
54.4 |
51.4 |
|
52.2 |
|
Interest expenses, bln rub |
|
|
3.05 |
12.6 |
2.56 |
2.56 |
6.18 |
|
8.23 |
|
|
Assets, bln rub |
|
|
422.5 |
1 264 |
691.2 |
691.2 |
574.1 |
|
399.4 |
|
Net Assets, bln rub |
? |
|
157.2 |
690.7 |
211.6 |
211.6 |
134.8 |
|
69.7 |
|
Debt, bln rub |
|
|
188.1 |
197.2 |
235.3 |
235.3 |
266.1 |
|
221.9 |
|
Cash, bln rub |
|
|
293.2 |
233.5 |
121.9 |
121.9 |
91.8 |
|
67.0 |
|
Net debt, bln rub |
|
|
-105.1 |
-36.2 |
113.4 |
113.4 |
174.3 |
|
154.9 |
|
|
Ordinary share price, rub |
|
|
142.8 |
66.1 |
5.78 |
5.78 |
9.21 |
|
13.2 |
|
Number of ordinary shares, mln |
|
|
27.2 |
32.2 |
33.4 |
33.4 |
36.5 |
|
50.0 |
|
|
Market cap, bln rub |
|
|
3 885 |
2 128 |
193 |
193 |
336 |
|
661 |
|
EV, bln rub |
? |
|
3 780 |
2 092 |
307 |
307 |
510 |
|
816 |
|
Book value, bln rub |
|
|
150 |
-190 |
-195 |
-215 |
-202 |
|
-103 |
|
|
EPS, rub |
? |
|
-2.15 |
-3.99 |
-13.9 |
-13.9 |
-3.69 |
|
-5.49 |
|
FCF/share, rub |
|
|
-0.65 |
-1.59 |
-2.01 |
-2.02 |
-0.34 |
|
-0.25 |
|
BV/share, rub |
|
|
5.53 |
-5.92 |
-5.82 |
-6.42 |
-5.54 |
|
-2.05 |
|
|
EBITDA margin, % |
? |
|
-21.1% |
-33.7% |
-139.9% |
-140.3% |
-32.0% |
|
-81.4% |
|
Net margin, % |
? |
|
-31.3% |
-48.1% |
-155.8% |
-155.8% |
-43.6% |
|
-93.6% |
|
FCF yield, % |
? |
|
-0.46% |
-2.40% |
-34.8% |
-34.9% |
-3.74% |
|
-1.90% |
|
ROE, % |
? |
|
-37.2% |
-18.6% |
-219.9% |
-219.9% |
-99.9% |
|
-393.9% |
|
ROA, % |
? |
|
-13.8% |
-10.2% |
-67.3% |
-67.3% |
-23.5% |
|
-68.7% |
|
|
P/E |
? |
|
-66.4 |
-16.6 |
-0.42 |
-0.42 |
-2.49 |
|
-2.41 |
|
P/FCF |
|
|
-219.3 |
-41.7 |
-2.87 |
-2.87 |
-26.7 |
|
-52.6 |
|
P/S |
? |
|
20.8 |
7.97 |
0.65 |
0.65 |
1.09 |
|
2.25 |
|
P/BV |
? |
|
25.8 |
-11.2 |
-0.99 |
-0.90 |
-1.66 |
|
-6.45 |
|
EV/EBITDA |
? |
|
-95.7 |
-23.3 |
-0.73 |
-0.73 |
-5.15 |
|
-3.42 |
|
Debt/EBITDA |
|
|
2.66 |
0.40 |
-0.27 |
-0.27 |
-1.76 |
|
-0.65 |
|
|
R&D/CAPEX, % |
|
|
173.3% |
303.3% |
408.9% |
403.6% |
414.4% |
|
228.0% |
|
|
CAPEX/Revenue, % |
|
|
5.41% |
4.70% |
4.46% |
4.52% |
4.01% |
|
7.81% |
|
| Cardlytics shareholders |
